Basic Research in Cardiology

, Volume 83, Issue 3, pp 268–276 | Cite as

Propranolol and thyroxine-induced hypertrophic rabbit hearts: Effect on heart size and regional O2 supply/consumption variables

  • G. J. Grover
  • J. M. Houghton
  • H. R. Weiss
Original Contributions


The purpose of this study was to determine the effect of acute and chronic propranolol on heart size and regional O2 supply/consumption variables in thyroxine (T4-treated rabbit hearts. New Zealand white rabbits were given 0.5 mg/kg T4 for 3 or 16 days with and without concomitant 2 mg/kg propranolol. Another group was given 16 days of propranolol alone and another 3-day T4 group was given 2 mg/kg propranolol 1 h before the experiment began. Another group served as control. Myocardial blood flows were determined using radioactive microspheres and small arteriolar and venous O2 saturations were determined using microspectrophotometry. Treatment with T4 for 3 or 16 days increased the heart weight/body weight ratio, myocardial blood flow, and regional O2 consumption. 16-day T4 treatment resulted in myocardial flow 195% and O2 consumption 300% above control group values. When propranolol was given chronically along with T4, heart weight/body weight ratios did not increase to the degree seen with 3 or 16 days of T4, alone. Propranolol given acutely in 3-day T4-treated animals, resulted in a reduced O2 consumption and O2 extraction, though not to the extent seen with chronic propranolol treatment of T4-treated animals. Acute propranolol treatment slightly reduced myocardial blood flow in 3-day T4-treated animals, while chronic treatment significantly reduced it. Chronic propranolol treatment in 16-day T4-treated animals resulted in a significant reduction in flow and O2 consumption. Thus, T4 treatment increased O2 consumption, flow, and heart size and these effects could be attenuated using acute and chronic propranolol.

Key words

propranolol cardiachypertrophy coronary blood flow myocardialoxygen consumption thyroxine 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Allely MC, Ungar A (1985) Interactions of β-adrenoceptor antagonists and thyroid hormones in the control of heart rate in the dog. Br J Pharmacol 86:393–398Google Scholar
  2. 2.
    Amidi M, Leon, DF, DeGrott WJ, Leonard JS (1968) Effect of thyroid state on myocardial contractility and ventricular ejection rate in man. Circulation 38:229–239Google Scholar
  3. 3.
    Beznak M (1962) Cardiovascular effects of thyroxine treatment in normal rats. Can J Biochem Physiol 40:1647–1654Google Scholar
  4. 4.
    Dole WP, Jackson DL, Rosenblatt JI, Thompson WL (1982) Relative error and variability in blood flow measurements with radiolabelled microspheres. Am J Physiol 243:H371-H378Google Scholar
  5. 5.
    Graettinger JS, Muenster JJ, Selverstone LA, Campbell JA (1959) A correlation of clinical and hemodynamic studies in patients with hyperthyroidism with and without congestive heart failure. J Clin Invest 38:1316–1327Google Scholar
  6. 6.
    Grossman W, Robin NI, Johnson LW, Brooks HL, Selenkow HA, Dexter L (1971) The enhanced myocardial contractility of thyrotoxicosis. Role of the Beta adrenergic receptor. Ann Int Med 74:869–874Google Scholar
  7. 7.
    Harrower ADB, Fyffe JA, Horn DR, Srong JA (1977) Thyroxine and triodothyronine levels in hyperthyroid patients during treatment with propranolol. Clin Endocrinol 7:41–44Google Scholar
  8. 8.
    Ho K, Lloyd BL, Taylor RR (1981) Cardiac β-adrenoceptors in the thyroxinc-treated dog. Clin Exp Pharmacol Physiol 8:183–187Google Scholar
  9. 9.
    Hoffmann F, Middleton S, Talensnik T (1949) Influence of the thyroid hormone in the effector systems of the mammalian heart. Am J Physiol 148:689–697Google Scholar
  10. 10.
    Holtz J, Restoff W, Bard P, Bassenge E (1977) Transmural distribution of myocardial blood flow and of coronary reserve in canine left ventricular hypertrophy. Basic Res Cardiol 72:286–292Google Scholar
  11. 11.
    Igawa T, Ikezono K, Watanabe K, Kimura Y (1984) Dose-related inhibitory effects of the β-adrenoceptor blocking drugs carteolol and propranolol on cardiac hypertrophy in spontaneously hypertensive rats. Eur J Pharmacol 104:93–99Google Scholar
  12. 12.
    Johnson L, Sciacca R, Ellis K, Weiss MB, Cannon PJ (1978) Reduced left ventricular myocardial blood flow per unit mass in aortic stenosis. Circulation 57:582–590Google Scholar
  13. 13.
    Kunos G (1977) Thyroid hormone-dependent interconversion of myocardial α- and β-adrenoceptors in the rat. Br J Pharmacol 59:177–183Google Scholar
  14. 14.
    Marchetti CV, Menlo L, Noseda V, Visioli O (1973) Myocardial blood flow in experimental cardiac hypertrophy in dogs. Cardiovasc Res 7:519–527Google Scholar
  15. 15.
    Marcus ML, Mueller TM, Fascho JA, Kerber RE (1979) Effects of cardiac hypertrophy secondary to hypertension on the coronary circulation. Am J Cardiol 44:1023–1028Google Scholar
  16. 16.
    Marcus ML, Doty DB, Hiratzka LF, Wright LB, Eastham CL (1982) Decreased coronary reserve. A mechanism for angina pectoris in patients with aortic stenosis and normal coronary arteries. New Engl J Med 307:1362–1366Google Scholar
  17. 17.
    Motz W, Ploeger M, Ringswandle G, Goeldel N, Gartgiff B, Kazda S, Straver BE (1983) Influence of nifedipine on ventricular function and myocardial hypertrophy in spontaneously hypertensive rats. J Cardivasc Pharmacol 5:55–61Google Scholar
  18. 18.
    Opie LH, Thandrogen FT, Muller C, Bricknell OL (1979) Adrenaline-induced oxygen wastage and enzyme release from working rat heart-effects of calcium antagonism, beta blockade, nicotinic acid and coronary artery ligitation. J Mol Cell Cardiol 11:1073–1094Google Scholar
  19. 19.
    Piatnek-Leunissen K, Olson RE (1967) Cardiac failure in the dog as a consequence of exogenous hyperthyroidism. Circ Res 20:242–252Google Scholar
  20. 20.
    Riddle M, Schwartz T (1970) New tactics for hyperthyroidism: Sympathetic blockade. Ann Int Med 72:749–751Google Scholar
  21. 21.
    Shanks RB, Hadden DR, Lowe DC, McDermitt DG, Montgomery DAD (1969) Controlled trial of propranolol in thyrotoxicosis. Lancet 1:993–994Google Scholar
  22. 22.
    Sinha AK, Neubauer JA, Lipp JA, Weiss HR (1977) Blood oxygen saturation determination in frozen tissue. Microvasc Res 13:133–144Google Scholar
  23. 23.
    Sharma VK, Banerjee SP (1977) Muscarinic cholinergic receptors in rat heart. Effects of thyroidectomy. J Biol Chem 252:7444–7451Google Scholar
  24. 24.
    Skelton CL, Coleman H, Wildenthal K, Braunwald E (1970) Augmentation of myocardial oxygen consumption in hyperthyroid cats. Circ Res 27:301–309Google Scholar
  25. 25.
    Strauer BE, Baver F, Brecht HM., Motz W (1985) The influence of sympathetic nervous activity on regression of cardiac hypertrophy. J Hypertension 3 (Suppl 4) S39-S44Google Scholar
  26. 26.
    Talafih K, Briden KL, Weiss HR (1983) Thyroxine-induced hypertrophy of the rabbit heart-effect on regional O2 extraction, flow, and O2 consumption. Circ Res 52:272–279Google Scholar
  27. 27.
    Thompson DS, Nagri N, Juul SM, Swanton RH, Coltart DJ, Jenkins BS, Webb-Peploe (1980) Effects of propranolol on myocardial oxygen consumption, substrate extraction, and haemodynamics in hypertrophic obstructive cardiomyopathy. Br. Heart J 44:488–495Google Scholar
  28. 28.
    Tomanek RJ, Searls JC, Lachenbruch PA (1982) Quantitative changes in the capillary bed during developing, peak, and stabilized cardiac hypertrophy in the spontaneously hypertensive rat. Circ Res 51:295–304Google Scholar
  29. 29.
    Tse J, Wrenn RW, Kuo JF (1980) Thyroxine-induced changes in characteristics and activities of β-adrenergic receptors and adenosine 3′,5′-monophosphate and guanosine 3′, 5′-monophosphate systems in the heart may be related to reputed catecholamine supersensitivity in hyperthyroidism. Endocrionology 107:6–16Google Scholar
  30. 30.
    Upsher ME, Weiss HR (1986) Heterogeneous distribution of beta adrenoceptors in the dog left ventricle. J Mol Cell Cardiol 18:657–660Google Scholar
  31. 31.
    Weiss HR, Sinha AK (1978) Regional O2 saturation of small arteries and veins in the canine myocardium. Circ Res 42:119–126Google Scholar
  32. 32.
    Wikman-Coffelt J, Parmley WW, Mason DT (1979) The cardiac hypertrophy process. Analyses of factors determining pathological vs, physiological development. Circ Res 45:597–707Google Scholar
  33. 33.
    Williams LT, Lefkowitz RJ, Watanabe AM, Hathaway DR, Besch HR (1977) Thyroid hormone regulation of β-adrenergic receptor number. J Biol Chem 252:2787–2789Google Scholar

Copyright information

© Dr. Dietrich Steinkopff Verlag 1988

Authors and Affiliations

  • G. J. Grover
    • 1
  • J. M. Houghton
    • 1
  • H. R. Weiss
    • 1
  1. 1.Heart and Brain Circulation Laboratory, Department of Physiology and BiophysicsUniversity of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical SchoolPiscatawayUSA

Personalised recommendations